Who
John Raymond Murphy
Director
Company insider
Files Form 4 as: Director, Cadrenal Therapeutics; Director, O'Reilly Automotive; Director, Summit Materials; Director, Apria; Director, Graham Packaging Co; President & CEO, Accuride.
In numbers
- Trades disclosed
- 241
- Buys
- 8
- Sells
- 49
- Bought
- $539K
- Sold
- $10.5M
- Companies
- 6
- Companies where not an officer
- 5
- First trade
- 26 Apr 2005
- Last trade
- 9 Oct 2026
- Last filed
- 13 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Oct 2026filed 13 Oct 2026 | CVKD Cadrenal Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —75,000 at $0.00 | filing |
| 18 May 2026filed 20 May 2026 | ORLY O'Reilly AutomotiveRetail — Specialty | SEC FORM 4 Sold | $230K2,595 at $88.67 | filing |
| 18 May 2026filed 20 May 2026 | ORLY O'Reilly AutomotiveRetail — Specialty | SEC FORM 4 Sold | $230K2,595 at $88.67 | filing |
| 15 May 2026filed 18 May 2026 | ORLY O'Reilly AutomotiveRetail — Specialty | SEC FORM 4 Code A | $180K2,035 at $88.49 | filing |
| 15 May 2026filed 18 May 2026 | ORLY O'Reilly AutomotiveRetail — Specialty | SEC FORM 4 Code A | $180K2,035 at $88.49 | filing |
| 4 Nov 2025filed 6 Nov 2025 | ORLY O'Reilly AutomotiveRetail — Specialty | SEC FORM 4 Sold | $289K3,125 at $92.60 | filing |
| 19 May 2025filed 20 May 2025 | ORLY O'Reilly AutomotiveRetail — Specialty | SEC FORM 4 Sold | $276K200 at $1,379.00 | filing |
| 16 May 2025filed 20 May 2025 | ORLY O'Reilly AutomotiveRetail — Specialty | SEC FORM 4 Code A | $181K131 at $1,381.66 | filing |
| 23 Jan 2025filed 24 Jan 2025 | CVKD Cadrenal Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 17 May 2024filed 21 May 2024 | ORLY O'Reilly AutomotiveRetail — Specialty | SEC FORM 4 Code A | $175K173 at $1,012.06 | filing |
| 13 Feb 2024filed 15 Feb 2024 | ORLY O'Reilly AutomotiveRetail — Specialty | SEC FORM 4 Sold | $280K269 at $1,039.28 | filing |
| 18 Jan 2024filed 19 Jan 2024 | CVKD Cadrenal Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 31 Oct 2023filed 2 Nov 2023 | ORLY O'Reilly AutomotiveRetail — Specialty | SEC FORM 4 Sold | $232K250 at $929.67 | filing |
| 5 Oct 2023filed 6 Oct 2023 | CVKD Cadrenal TherapeuticsBiotechnology | SEC FORM 4 Bought | $1,8422,669 at $0.69 | filing |
| 4 Oct 2023filed 6 Oct 2023 | CVKD Cadrenal TherapeuticsBiotechnology | SEC FORM 4 Bought | $12K17,331 at $0.70 | filing |
| 29 Sep 2023filed 2 Oct 2023 | Summit Materialsoption or derivative | SEC FORM 4 Code C | —4,274 | filing |
| 29 Sep 2023filed 2 Oct 2023 | Summit Materials | SEC FORM 4 Code C | —4,274 | filing |
| 19 May 2023filed 23 May 2023 | ORLY O'Reilly AutomotiveRetail — Specialty | SEC FORM 4 Code A | $161K169 at $954.30 | filing |
| 2 May 2023filed 4 May 2023 | ORLY O'Reilly AutomotiveRetail — Specialty | SEC FORM 4 Sold | $277K300 at $924.56 | filing |
| 21 Mar 2023filed 22 Mar 2023 | CVKD Cadrenal TherapeuticsBiotechnology | SEC FORM 4 Bought | $14K10,000 at $1.39 | filing |
News
O'Reilly Automotive (NASDAQ:ORLY) & Tilly's (NYSE:TLYS) Head to Head ContrastORLY · themarketsdaily.com · 18 Oct 2026Western Financial Corp CA Sells 18,249 Shares of O'Reilly Automotive, Inc. $ORLYORLY · dailypolitical.com · 15 Oct 2026O'Reilly Automotive (ORLY) vs. AZO and GPC: Why Auto Parts Stocks Are No Longer Safe HavensORLY · insidermonkey.com · 5 Oct 2026
0 headlines in the last 90 days name John Raymond Murphy; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.